CSF3 and cancer: Recombinant human G-CSF (filgrastim) is used in clinical practice for mobilisation of haematopoietic progenitor cells in cancer patients with chemotherapy-induced neutropenia and those receiving chemotherapy prior to undergoing bone marrow transplantation [19].